Esanex Obtains $10,746,664 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3ae79703-9688-4b55-9929-68ba7919a754&Preview=1 - Date
12/12/2012 - Company Name
Esanex - Mailing Address
115 W. Washington St. Indianapolis, IN 46204 - Company Description
Esanex, Inc. is a United States-based pharmaceutical company. - Website
Undisclosed
- Transaction Type
Venture Equity - Transaction Amount
$10,746,664 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
